Literature DB >> 16356493

Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation.

Patrizia Gazzerro1, Ciro Abbondanza, Andrea D'Arcangelo, Mariangela Rossi, Nicola Medici, Bruno Moncharmont, Giovanni Alfredo Puca.   

Abstract

The retinoblastoma protein-interacting zinc-finger (RIZ) gene, a member of the nuclear protein methyltransferase superfamily, is characterized by the presence of the N-terminal PR domain. The RIZ gene encodes for two proteins, RIZ1 and RIZ2. While RIZ1 contains the PR (PRDI-BF1 and RIZ homologous) domain, RIZ2 lacks it. RIZ gene expression is altered in a variety of human cancers and RIZ1 is now considered to be a candidate tumor suppressor. Estradiol treatment of MCF-7 cells produced a selective decrease of RIZ1 transcript and an increase of total RIZ mRNA. Experiments of chromatin immunoprecipitation indicated that RIZ2 protein expression was controlled by estrogen receptor and RIZ1 had a direct repressor function on c-myc gene expression. To investigate the role of RIZ gene products as regulators of the proliferation/differentiation transition, we analyzed the effects of forced suppression of RIZ1 induced in MCF-7 cells by siRNA of the PR domain-containing form. Silencing of RIZ1 expression stimulated cell proliferation, similar to the effect of estradiol on these cells, associated with a transient increase of c-myc expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356493     DOI: 10.1016/j.yexcr.2005.11.002

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

2.  Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.

Authors:  Shang-Wen Dong; Peng Zhang; Yi-Mei Liu; Yuan-Tao Cui; Shuo Wang; Shao-Jie Liang; Zhun He; Pei Sun; Yuan-Guo Wang
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

3.  Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.

Authors:  Fei Zhao; Yan Chen; Ling-lan Zeng; Rui Li; Rong Zeng; Lu Wen; Yuan Liu; Chun Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

4.  Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation.

Authors:  Shang-Wen Dong; Dong Li; Cong Xu; Pei Sun; Yuan-Guo Wang; Peng Zhang
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

5.  Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells.

Authors:  H Y Cheng; T Zhang; Y Qu; W J Shi; G Lou; Y X Liu; Y Y Zhang; L Cheng
Journal:  Cancer Gene Ther       Date:  2016-10-07       Impact factor: 5.987

6.  Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma.

Authors:  Prasong Khaenam; Patcharee Jearanaikoon; Chawalit Pairojkul; Vajarabhongsa Bhudhisawasdi; Temduang Limpaiboon
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

7.  Construction of PR domain eukaryotic expression vector and its inhibitory effect on esophageal cancer cells.

Authors:  Yuan Chen; Peng Zhang; Yuanguo Wang; Shangwen Dong; Yimei Liu
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 8.  Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?

Authors:  Ewa M Michalak; Jane E Visvader
Journal:  Mol Oncol       Date:  2016-09-23       Impact factor: 6.603

9.  A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene.

Authors:  Sirisha Cheedipudi; Deepika Puri; Amena Saleh; Hardik P Gala; Mohammed Rumman; Malini S Pillai; Prethish Sreenivas; Reety Arora; Jeeva Sellathurai; Henrik Daa Schrøder; Rakesh K Mishra; Jyotsna Dhawan
Journal:  Nucleic Acids Res       Date:  2015-06-03       Impact factor: 16.971

10.  PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.

Authors:  Erika Di Zazzo; Caterina De Rosa; Ciro Abbondanza; Bruno Moncharmont
Journal:  Biology (Basel)       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.